Device makers doing business in the U.S. have had a much more stable regulatory regime than has been true for companies in other jurisdictions, but that will shift somewhat in 2025. Brynn Stanley of ...
Inspectors found 111 open tickets for software defects categorized as catastrophic or severe patient harm. Several safety complaints were also listed that BD didn’t report within the required ...
The FDA has issued a warning letter related to BD Pyxis automated medication dispensing systems — technology that was part of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback